Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events

Mohammad Zubaid, Wafa A. Rashed, Alawi A. Alsheikh-Ali, Ibrahim Al-Zakwani, Wael AlMahmeed, Abdullah Shehab, Kadhim Sulaiman, Ahmed Al Qudaimi, Nidal Asaad, Haitham Amin

Research output: Contribution to journalArticle

12 Citations (Scopus)


We describe management and outcomes of patients with nonvalvular atrial fibrillation (AF) in the Middle East. Consecutive patients with AF presenting to emergency departments (EDs) were prospectively enrolled. Among 1721 patients with nonvalvular AF, mean age was 59 ± 16 years and 44% were women. Comorbidities were common such as hypertension (59%), diabetes (33%), and coronary artery disease (33%). Warfarin was not prescribed to 40% of patients with Congestive heart failure, Hypertension, Age, Diabetes mellitus, Stroke/TIA2 score of ≥2. One-year rates of stroke/transient ischemic attack (TIA) and all-cause mortality were 4.2% and 15.3%, respectively. Warfarin use at hospital-ED discharge was independently associated with lower 1-year rate of stroke/TIA (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.17-0.85; P =.015) and all-cause mortality (OR, 0.51; 95% CI, 0.32-0.83; P =.006). Prior history of heart failure and peripheral vascular disease was independent mortality predictors. Our patients are relatively young with significant cardiovascular risk. Their anticoagulation treatment is suboptimal, and 1-year all-cause mortality and stroke/TIA event rates are relatively high.

Original languageEnglish
Pages (from-to)464-471
Number of pages8
Issue number5
Publication statusPublished - May 21 2015



  • anticoagulation
  • atrial fibrillation
  • Middle East
  • risk assessment
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this